Testing effectiveness (Phase 2)Enrolling By InvitationNCT04836390
What this trial is testing
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
Who this might be right for
Acute Myeloid Leukemia
Michael Pulsipher 30